Enrolment and logistical challenges in TaMoVac 01 Phase I/II HIV trial despite the completion of an earlier (HIVIS-03 trial trial) in Dar es Salaam by Ngatoluwa M, Munseri P, Janabi M, Mhalu F, Sandstrom E, Bakari M

High prevalence of ECG variations and abnormalities in young and healthy TaMoVac 01 HIV vaccine trial volunteers from Tanzania by Mann PJ, Munseri P, Kaluwa B, Missanga M, Lwakatare J, Hoelscher M, Bakari M, Janabi M, Maboko L, Sandström E, Kroidl A

Priming with a “simplified regimen” of HIV-1 DNA vaccine is as good as a “standard regimen” when boosted with heterologous HIV-1 MVA vaccine by Munseri P, Kroidl A, Nilsson C, Moshiro C, Aboud S, Joachim A, Geldmacher C, Aris E, Buma D, Lyamuya E, Gotch F, Godoy-Ramirez K, Pallangyo K, Maboko L, Marovich M, Robb M, Hoelscher M, Janabi M, Mann P, Joseph S, Mfinanga S, Stoehr W, Mhalu F, Wahren B, Biberfeld G, McCormack S, Sandstrom E, Bakari M

Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual pat... by Barr, DA, Lewis, JM, Feasey, N, Schutz, C, Kerkhoff, AD, Jacob, ST, Andrews, B, Kelly, P, Lakhi, S, Muchemwa, L, Bacha, HA, Hadad, DJ, Bedell, R, van Lettow, M, Zachariah, R, Crump, JA, Alland, D, Corbett, EL, Gopinath, K, Singh, S, Griesel, R, Maartens, G, Mendelson, M, Ward, AM, Parry, CM, Talbot, EA, Munseri, P, Dorman, SE, Martinson, N, Shah, M, Cain, K, Heilig, CM, Varma, JK, von Gottberg, A, Sacks, L, Wilson, D, Squire, SB, Lalloo, DG, Davies, G, Meintjes, G